PRUDENTIAL FINANCIAL INC

Position in EDIT — Editas Medicine, Inc.

CIK 1137774 NEWARK, NJ

Position in EDIT

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$163,909

+$124,154 QoQ

Shares Held

66,360

+479.2% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRUDENTIAL FINANCIAL INC holds $506,574,956 across 170 Biotechnology names. EDIT ranks #115 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	140,491	$108,548,965
2	VRTX	Vertex Pharmaceuticals Inc / Ma	131,560	$58,746,801
3	INCY	Incyte Corp	374,280	$35,227,233
4	EXEL	Exelixis, Inc.	463,825	$19,893,454
5	LGND	Ligand Pharmaceuticals Inc	64,133	$12,804,153
6	ALMS	Alumis Inc.	538,733	$11,868,287
7	PTCT	Ptc Therapeutics, Inc.	164,570	$11,212,154
8	PTGX	Protagonist Therapeutics, Inc	95,235	$10,037,769

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$163,909	66,360	+479.2%	Shares	Defined	2026-05-13
2025-09-30	$39,755	11,457	-11.4%	Shares	Defined	2025-11-13
2025-06-30	$28,461	12,937	-83.8%	Shares	Defined	2025-08-12
2025-03-31	$92,726	79,937	-59.4%	Shares	Defined	2025-05-13
2024-12-31	$250,160	196,977	+35.5%	Shares	Defined	2025-02-11
2024-09-30	$495,735	145,377	+41.1%	Shares	Defined	2024-11-14
2024-06-30	$481,046	103,008	+70.3%	Shares	Defined	2024-08-13
2024-03-31	$448,917	60,501	+942.2%	Shares	Defined	2024-05-14
2021-12-31	$154,122	5,805	-45.4%	Shares	Defined	2022-02-14
2021-09-30	$436,803	10,633	+93.6%	Shares	Defined	2021-11-15
2021-06-30	$311,066	5,492	+2.4%	Shares	Defined	2021-08-16
2021-03-31	$225,288	5,364	+7.4%	Shares	Defined	2021-05-12
2020-12-31	$350,199	4,995	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.